- Nabta Health closes a $2M Pre-Series A round, bringing total funding to $4.5M, to scale its AI-powered hybrid women’s health model.
- New capital will support expansion across the Middle East and Africa, development of diagnostic and at-home testing pathways, and strengthened clinical partnerships.
-
Nabta was recognized among TIME Magazine’s Top HealthTech Companies 2025 and launched a new Women’s Health Centre of Excellence in Dubai.
UAE-based Nabta Health has announced the closure of a $2 million Pre-Series A funding round, bringing its total funding to $4.5 million. The healthtech company, founded in 2017 by Sophie Smith, is transforming women’s healthcare in the Middle East through a hybrid care model that integrates AI-powered digital services, at-home care, and in-clinic clinical pathways.
A Model Designed for Women’s Health Needs in the MEA Region
Nabta’s hybrid approach is designed to bridge critical gaps in women’s health by combining mobile-first digital solutions with accessible testing and clinical care. With the new capital, the company plans to:
-
Expand operations across the Middle East and Africa
-
Develop new diagnostic and at-home testing pathways
-
Strengthen clinical infrastructure through hospital partnerships
-
Deepen collaboration with employers, insurers, and healthcare providers
These steps aim to position Nabta as the region’s leading integrated women’s health ecosystem.
Press Release: Nabta Health’s Pre-Series A Round
Nabta Health (“NABTA”) is pleased to announce the closing of a $2 million Pre-Series A funding round, bringing its total funding to date to US $4.5 million.
The Pre-Series A funding will enable NABTA to accelerate its mission to deliver accessible, evidence-based women’s healthcare and to expand its AI-powered hybrid model across the Middle East and Africa.
The investment will be used to deepen partnerships with employers, insurers, and healthcare providers; introduce new diagnostic and at-home testing pathways; and strengthen NABTA’s clinical infrastructure in collaboration with leading hospitals.
This year, NABTA was named to TIME Magazine’s Top HealthTech Companies 2025 list, announced the launch of a Women’s Health Centre of Excellence in partnership with Clemenceau Medical Center Hospital Dubai, and expanded its corporate health solutions across the region.
Together, these milestones reflect NABTA’s growing role as the MEA region’s hub for innovation in women’s health – a model that blends virtual, in-clinic, and community care to improve health outcomes across every stage of a woman’s life.
Leadership Statements
Sophie Smith, Founder and CEO, Nabta Health, said:
“We are delighted to have closed this Pre-Series A round and to bring our total funding to date to US$4.5 million. This investment validates our vision – that women’s health in the region can be reimagined through an AI-powered, hybrid care model that meets women where they are, respects cultural context and delivers measurable outcomes. We are now looking to accelerate our growth so that more women and employers benefit from what we believe is the future of women-centred health: affordable, mobile-first, and engineered for sovereignty.”
She added:
“For employers and insurers in the region, addressing the women’s health gap is not just a moral imperative; it is a business and productivity one. With this funding, we will drive scale, deepen impact and prepare for the next chapter of growth.”
Iain McMillan, Chair, Nabta Health, said:
“The closing of this Pre-Series A round is confirmation that Nabta Health is being increasingly recognised in the region as a key enabler of measurably better women’s health. The business has steadily gained traction and grown its customer base throughout 2025 and I am looking forward to seeing further acceleration in our success as we move forward into 2026 and beyond.”
العربية (Arabic) To read the article in Arabic, click here
